跳至主要内容
临床试验/KCT0005775
KCT0005775招募中未知

Appropriate Duration of Anti-Platelet straTegy in patients with advance Chronic Kideny Disease after new generation drug eluting stents (ADAPT-CKD)

Yonsei University Health System, Severance Hospital0 个研究点目标入组 900 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 84(Year)(—)
性别
All

入选标准

  • 1. Over 19 years old
  • 2. Chronic Renal Failure Stage IIIb, IV, V (CKD-EPI eGFR <45 / <30 / <15 or dialysis)
  • 3. Patients treated with a new generation drug eluting stent.
  • 4. Patients who signed consent form

排除标准

  • 1. Over 85 years old
  • 2. Patients with high risk of bleeding
  • 1) History of hemorrhagic stroke
  • 2) Stroke, dementia or central nervous system damage within 1 year
  • 3) Head trauma or brain surgery within 6 months
  • 4) Tumor in the skull
  • 5) If aortic dissection is suspected
  • 6) Internal bleeding within 6 weeks
  • 7) In case of active bleeding or bleeding disorder
  • 8) In case of major surgery, trauma or bleeding within 3 weeks
  • 3. Patients who need oral anticoagulant
  • 4. Pregnant women or women of childbearing age
  • 5. Life expectancy is less than 1 year
  • 6. Patients with a history of intracranial bleeding
  • 7. Moderate to severe hepatic impairment (Child-Pugh class B or C)

研究者

相似试验